Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Ontario to provide $420m for cancer research

Government of Ontario will provide a five-year funding support up to $420m to The Ontario Institute for Cancer Research (OICR) to focus on research into the prevention, early detection, diagnosis and treatment of cancer.

The funding will also help Ontario Health Study to complete recruitment plans for the study which will lead to prevention of cancer and other chronic diseases.

OICR president and scientific director Tom Hudson said the cancer trials being conducted in 23 adult and 5 paediatric cancer centres in Ontario can help bring new cancer therapies to Ontario cancer patients.

”With renewed funding we will continue the work, ensuring the most promising cancer research in Ontario will be turned into new treatments and provide new hope for cancer patients worldwide,” Hudson added.

OICR is conducting research on small molecules, biologics, stem cells, imaging, genomics, informatics and bio-computing right from early stage research to phase II clinical trials.

OICR can fulfill its goals set out in its 2010-25 strategic plan that aims to adopt personalized approaches to diagnose and treat cancer.